Skip to content
Sign in
Venture capitalBacked 1 network startup

GridX

Buenos Aires biotech fund and company builder backing pre-seed and seed Latin American life-science startups.

Buenos Aires, Argentina
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Pre-seedto Seed
Network startups backed
1
Co-investors
1most often with ATGen

How they invest

Biotech and life sciences in Latin America, often building companies around scientists. Backed Uruguayan nanobody company Nanogrow Biotech.

Stage and ticket

Pre-seed and seed; ticket not disclosed (Nanogrow seed round: $1.2M).

Geography

Latin America.

What makes them say yes

  • Science-founder team with proprietary biology platform
  • LatAm base with global market ambition
  • Pre-seed/seed company that benefits from company-building support

Red flags

  • Non-biotech software
  • Companies outside Latin America

Sectors

  • Biotech & life sciences

Stages

  • Pre-seed
  • Seed

Geographies

  • Latin America

How to approach

Ask Nanogrow Biotech's founders (GridX seed) for an intro; lead with the scientific platform and IP.

Portfolio

1 network startup · no other company

LatAm biotech platform (nanobodies) co-backed with ATGen — science-first company building.

Gaps in the portfolio

  • Therapeutics
  • Agri-biotech
  • Diagnostics

Network startups

  • Nanogrow BiotechSWC 2026 Finalist

    Uruguay-Spain nanobody company pairing single-domain antibodies with local delivery for asthma, colorectal cancer, psoriasis and atopic dermatitis.

    Uruguay · Biotech & life sciences

Network startups that fit

3 analysed

Argentine marketplace turning de-identified records from a 47–84-facility Latin American network into research- and AI-ready clinical datasets.

Argentine real-world health data at pre-seed — home city/country; data is complementary to biotech R&D but not a biology platform.

35%confidence

Evidence from the records

  • “Argentine biotech fund and company builder”
  • “Health data / real-world data”
  • “Marketplace in operation: claimed network of 47 to 84+ healthcare facilities in 5 countries (Argentina, Uruguay, Mexico, Dominican Rep., Brazil)”
Intro path
Founder-to-founder intro via Nanogrow Biotech (network portfolio company of GridX).
First step
Position RWD as infrastructure for LatAm biotech trials.

Mexican menopause FemTech pairing saliva hormone kits with AI symptom tracking, already retailing in Hong Kong through Mannings pharmacies.

Mexican femtech for menopause — LatAm health, but consumer health rather than biotech.

25%confidence

Evidence from the records

  • “"Latin America"”
  • “FemTech – perimenopause / menopause”
  • “Kit sold in Hong Kong through the Mannings pharmacy chain.”
Intro path
Founder-to-founder intro via Nanogrow Biotech (network portfolio company of GridX).
First step
Only if Hormony develops a proprietary bio-based product.

Physician-led Puerto Rican medtech pairing 222 nm UVC wound therapy with AI clinical software; evidence still thin.

Puerto Rico UV phototherapy for chronic wounds — life-science-adjacent and Start-Up Chile-backed; device rather than biotech.

25%confidence

Evidence from the records

  • “"Pre-seed","Seed"”
  • “UV phototherapy for chronic wounds + AI clinical software”
  • “Uncontrolled case study on 5 patients (chronic wounds) and multicenter before/after study on surfaces published on the website”
Intro path
Founder-to-founder intro via Nanogrow Biotech (network portfolio company of GridX).
First step
Low priority; test interest in medtech.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with ATGen

Sources

  1. 1descubre.vc/noticia/gridx-el-fondo-y-aceleradora-de-biotech-argentina-2
  2. 2seedtable.com/investors/gridx

Profile compiled from public sources. Unknown fields are left empty rather than estimated.